Pharmaceutical Technology

JUNE 9, 2025

Give your business an edge with our leading industry insights.

Communication 52

Communication Hospitals Drug Pricing Packaging 52

Pharmaceutical Technology

JUNE 9, 2025

Give your business an edge with our leading industry insights.

Communication 52

Communication Hospitals Drug Pricing Packaging 52

Pharmaceutical Technology

FEBRUARY 7, 2023

An example is NICE’s Quality Adjusted Life Year score, used to price drugs in the UK. Some nations such as France base their decisions on the drug’s medical benefit and clinical added value versus existing therapies. Overall, it is never too soon to begin market access activities, but it can easily be too late.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Inpatient Drug Pricing Packaging 52

Pharmaceutical Technology

JUNE 6, 2025

Give your business an edge with our leading industry insights.

Communication 52

Communication Hospitals Drug Pricing Packaging 52

Pharmaceutical Technology

JUNE 10, 2025

By GlobalData Learn more about Strategic Intelligence In April, GlobalData business fundamentals analyst Alison Labya said: “The Trump administration has introduced uncertainty to the biopharmaceutical industry across healthcare policies, drug pricing reforms, and regulatory frameworks, all of which could impact investor confidence.

Drug Pricing 52

Drug Pricing Communication Hospitals Packaging 52

Pharmaceutical Technology

JUNE 10, 2025

Go deeper with GlobalData Reports United States of America (USA) Drug Pricing and Reimbursement Lands. Nominate Now Share Copy Link Share on X Share on Linkedin Share on Facebook Go deeper with GlobalData Reports United States of America (USA) Drug Pricing and Reimbursement Lands.

Vaccines 52

Vaccines Insurance Coverage and Processing Drug Pricing Immunity 52

Pharmaceutical Technology

JUNE 18, 2025

Amid President Donald Trump’s stated desire to sharply reduce drug prices on the US market, India has also proposed to supply generic medicines at between 20% and 25% of the current reference branded prices, for three years after originator patent expiry. Give your business an edge with our leading industry insights.

Drug Pricing 52

Drug Pricing Communication Pharmaceutical Companies Pharmaceutical Companies 52